Trade Summary

3 days ago, Reich Kristian, serving as Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 150,000 shares at $19.01 per share, for a total transaction value of $2,851,000.00. Following this transaction, Reich Kristian now holds 2,824,551 shares of MLTX.

This sale represents a 5.04% decrease in Reich Kristian's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 17, 2026 at 6:15 PM ET, 2 days after the trade was made.

MoonLake Immunotherapeutics operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.